Globeflex Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,155
Closed -$152K 420
2025
Q1
$152K Hold
9,155
0.01% 330
2024
Q4
$168K Buy
+9,155
New +$168K 0.01% 330